Procter & Gamble Currently Up Eight Consecutive Days, On Track for Longest Winning Streak Since April 2023 — Data Talk
Procter & Gamble Company (PG) is currently at $162.05, up $0.55 or 0.34%
--Would be highest close since March 28, 2024, when it closed at $162.25
--Currently up eight consecutive days; up 4.33% over this period
--Longest winning streak since April 6, 2023, when it rose for eight straight trading days
--Best eight day stretch since the eight days ending Feb. 1, 2024, when it rose 7.66%
--Down 0.12% month-to-date; on pace for worst month since Dec. 2023, when it fell 4.55%
--Up 10.58% year-to-date
--Down 1.32% from its all-time closing high of $164.21 on Jan. 5, 2022
--Up 4.83% from 52 weeks ago (April 26, 2023), when it closed at $154.58
--Down 0.34% from its 52-week closing high of $162.61 on March 27, 2024
--Up 13.72% from its 52-week closing low of $142.50 on May 31, 2023
--Traded as high as $162.34; highest intraday level since March 28, 2024, when it hit $163.14
--Up 0.52% at today's intraday high
--Eighth best performer in the DJIA today
--Contributed 3.61 points to the DJIA so far today
All data as of 1:30:24 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 24, 2024 13:47 ET (17:47 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
After Earnings, Is Berkshire Hathaway Stock a Buy, a Sell, or Fairly Valued?
-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom